• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • All News Archive
  • Listen to this page using ReadSpeaker
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

All News Archive

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

This section contains multiple pages. Click on each page number to advance the page.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 32 Next >
Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.)

April 2, 2012

Ethicon Endo-Surgery Partners With CBS HealthWatch to Educate About Colorectal Cancer, the Importance of Early Detection and Lifesaving Treatment Options

March 28, 2012

Ortho-Clinical Diagnostics, Inc. Announces Availability of HTLV-I/II Assay

March 28, 2012

New Edition Of Healthy Visiontm With Dr. Val Jones Kicks Off Sports Eye Safety Month With Information and Advice on Eye Protection and Protective Eyewear

March 28, 2012

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review

March 27, 2012

XARELTO® (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study

March 26, 2012

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 32 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • All News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

All News Archive

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 32 Next >
Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.)

April 2, 2012

Ethicon Endo-Surgery Partners With CBS HealthWatch to Educate About Colorectal Cancer, the Importance of Early Detection and Lifesaving Treatment Options

March 28, 2012

Ortho-Clinical Diagnostics, Inc. Announces Availability of HTLV-I/II Assay

March 28, 2012

New Edition Of Healthy Visiontm With Dr. Val Jones Kicks Off Sports Eye Safety Month With Information and Advice on Eye Protection and Protective Eyewear

March 28, 2012

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review

March 27, 2012

XARELTO® (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study

March 26, 2012

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 32 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •